NEW YORK, January 11, 2019 /PRNewswire/ --

U.S. stocks continued their climb throughout the week, lifted by ongoing trade discussions between the U.S. and China. Investors seemed optimistic about the talks, especially after U.S. President Donald Trump tweeted that the "talks were going well," on Tuesday. On Thursday, however, major retailers reported disappointing sales results and provided weaker guidance, causing the Dow Jones Industrial Average to slide nearly 200 points shortly after the opening bell. Macy's led the charge as its share price tumbled by 19%. Other major retailers such as Kohl's fell by as much 10%, while Target Corporation fell by 4.9%. However, markets quickly rebounded throughout Thursday as the Dow Jones closed higher once again, marking five straight days of gains. The Dow Jones gained approximately 533.98 points or 2.27% since last Friday's close into Thursday's close, pushing the Dow to over 24,000 points. The S&P 500 gained 64.48 points or 2.5% during the same period while the Nasdaq Composite rose by 248.5 points or 3.6%. Eli Lilly and Company (NYSE: LLY), Union Pacific Corporation (NYSE: UNP), Kohl's Corporation (NYSE: KSS), Target Corporation (NYSE: TGT), American Airlines Group Inc. (NASDAQ: AAL)

"The power of the recovery rally in US and global equities has been impressive," Michael Shaoul, Chairman and Chief Executive Officer of Marketfield Asset Management, wrote in a note to clients, according to CNBC. "As encouraging as all of this has been to witness it does not change the fact that a sell-off of this magnitude does not happen in a vacuum. The decline marks a key downward-shift in the long technology driven bull market. There is simply no way to tell at present whether we have witnessed the completion of a brief but tumultuous sell-off."

Eli Lilly and Company (NYSE: LLY) announced on Monday that it has entered into an agreement to acquire Loxo Oncology (NASDAQ: LOXO) for USD 235.00 per share or a transaction valued at approximately USD 8.0 Billion. Loxo Oncology shares surged by 65.4% following the announcement. Through the acquisition, Lilly will broaden its cancer treatment efforts with Loxo Oncology's technology and abilities.

Union Pacific Corporation (NYSE: UNP) shares gained 8% on Tuesday after the Company announced Jim Vena as its new Chief Operating Officer. Vena will oversee Union Pacific's operations, including its Unified Plan 2020 implementation. Vena joins Union Pacific two years after ending his 40-year tenure with rival Canadian National.  

Kohl's Corporation (NYSE: KSS) reported its comparable sales for the combined months of November and December. The retailer reported weaker-than-expected holiday sales, which sent shares tumbling down by as much as 9% on Thursday. For the two months, Kohl's reported that comparable sales for the holidays increased by 1.2% compared to its 7% increase the same period last year. Based on the results, Kohl's raised its lower-end fiscal 2018 earnings per share guidance to USD 5.50 to USD 5.55 compared to its previous guidance of USD 5.35 to USD 5.55.

Target Corporation (NYSE: TGT) announced its comparable sales report for November and December. Despite topping analysts' estimates, Target shares fell by 4% on Thursday due to weakness in the retail sector. Target reported that comparable sales for the two months grew by 5.7%, outpacing its 3.4% growth rate last year. Based on the strong results, Target now expects full-year comparable sales to grow approximately 5%. The Company also forecast adjusted earnings per share of USD 5.30 to USD 5.50 compared to analysts' estimates of USD 5.39.

American Airlines Group Inc. (NASDAQ: AAL) shares fell by 10% on Thursday after the Company slashed its profit forecast and warned investors that it struggled to produce revenue growth at the end of 2018. American Airlines said that its revenue seat per mile rose by 1.5% year over year compared to its previous forecast of 1.5% to 3.5%. The airline also said it expects to earnings per share to be between USD 4.40 to USD 4.60, which is lowered from its previous expectations of USD 4.50 to USD 5.00.

Follow us on Twitter for real time Financial News Updates: https://twitter.com/FinInsiders

Follow and talk to us on Instagram: https://www.instagram.com/financialinsiders/

Facebook Like Us to receive live feeds: https://www.facebook.com/financialinsiders/

About FinancialInsiders.com  

Financialinsiders.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially-driven digital space, video production and integration of social media, FinancialInsiders.com creates 100% unique original content. FinancialInsiders.com also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

Please Note: Financialinsiders.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.Financialinsiders.com (the "site") is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content), Financialinsiders.com, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. Financialinsiders.com has not been compensated directly by any of the companies mentioned here in this editorial. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. Financialinsiders.com receives fees for producing and presenting high quality and sophisticated content on Financialinsiders.com along with other financial news PR media services. Financialinsiders.com does not offer any personal opinions or bias commentary as we purely incorporate public market information along with financial and corporate news. Financialinsiders.com only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For this release, Financialinsiders.com has not been compensated for financial news dissemination and PR services by any parties. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. Financialinsiders.com will always disclose any compensation in securities or cash payments for financial news PR advertising. FinancialInsiders.com does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security. Financialinsiders.com, members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. Financialinsiders.com. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by Financialinsiders.com constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by Financialinsiders.com. Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: http://www.Financialinsiders.com.

Media Contact:
info@Financialinsiders.com
+1-212-381-6028

SOURCE Financialinsiders.com

Copyright 2019 PR Newswire

LOXO ONCOLOGY, INC. (NASDAQ:LOXO)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more LOXO ONCOLOGY, INC. Charts.
LOXO ONCOLOGY, INC. (NASDAQ:LOXO)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more LOXO ONCOLOGY, INC. Charts.